Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests
Status:
Withdrawn
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is a double-blind study with respect to the diluents used, with patients known to be
allergic to the specific allergen tested. Three study sites will be involved, each testing
one allergen (Cat, Mite, Timothy grass pollen). Subjects who are known to be allergic to the
allergen in question will be tested with serial three-fold dilutions to determine the ID 50
and relative extract potency using the method described by Turkeltaub.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Bryan Martin, DO
Collaborator:
American College of Allergy, Asthma and Immunology